IMUX (Immunic) E10: $-204.26 (As of Mar. 2026)


IMUX Immunic Inc IMUX
32 GF Score
Price $15.07
! 3 Warning Signs
View Full Analysis

What is Immunic E10?

Immunic IMUX 32 E10 is $-204.26 as of Mar. 2026. GuruFocus rates IMUX with a GF Score™ of 32/100. The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Immunic's adjusted earnings per share data for the three months ended in Mar. 2026 was $-1.080. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-204.26 for the trailing ten years ended in Mar. 2026.

During the past 3 years, the average E10 Growth Rate was 30.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Immunic was 30.10% per year. The lowest was 30.10% per year. And the median was 30.10% per year.

As of today (2026-06-26), Immunic's current stock price is $15.07. Immunic's E10 for the quarter that ended in Mar. 2026 was $-204.26. Immunic's Shiller PE Ratio of today is .


Immunic  (NAS:IMUX) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Immunic E10 Related Terms


Immunic E10 Historical Data

* Premium members only.

The historical data trend for Immunic's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Immunic E10 Chart

Immunic Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 -636.55 -454.63 -322.59 -217.21

Immunic Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -293.54 -262.22 -236.32 -217.21 -204.26

IMUX vs KPTI, INDP, UNCY: E10 Comparison

For the Biotechnology subindustry, Immunic's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Immunic Shiller PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Immunic's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Immunic's Shiller PE Ratio falls into.


IMUX
32GF Score
Immunic Inc IMUX
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Immunic E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Immunic's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=-1.08/330.2130*330.2130
=-1.080

Current CPI (Mar. 2026) = 330.2130.

Immunic Quarterly Data

per share eps CPI Adj_EPS
201606 -120.000 241.018 -164.409
201609 -128.000 241.428 -175.072
201612 -148.000 241.432 -202.424
201703 -156.000 243.801 -211.292
201706 -116.000 244.955 -156.374
201709 -120.000 246.819 -160.545
201712 -140.000 246.524 -187.527
201803 -136.000 249.554 -179.957
201806 -120.000 251.989 -157.251
201809 -112.000 252.439 -146.506
201812 -24.000 251.233 -31.545
201903 -50.900 254.202 -66.120
201906 -15.200 256.143 -19.595
201909 -8.200 256.759 -10.546
201912 -5.600 256.974 -7.196
202003 -7.900 258.115 -10.107
202006 -9.000 257.797 -11.528
202009 -7.000 260.280 -8.881
202012 -4.600 260.474 -5.832
202103 -16.300 264.877 -20.321
202106 -8.200 271.696 -9.966
202109 -7.600 274.310 -9.149
202112 -6.000 278.802 -7.106
202203 -7.400 287.504 -8.499
202206 -7.200 296.311 -8.024
202209 -6.900 296.808 -7.677
202212 -16.200 296.797 -18.024
202303 -5.800 301.836 -6.345
202306 -5.400 305.109 -5.844
202309 -5.100 307.789 -5.472
202312 -4.800 306.746 -5.167
202403 -3.000 312.332 -3.172
202406 -2.100 314.175 -2.207
202409 -2.400 315.301 -2.514
202412 -2.500 315.605 -2.616
202503 -2.510 319.799 -2.592
202506 -2.000 322.561 -2.047
202509 -1.300 324.800 -1.322
202512 -0.700 324.054 -0.713
202603 -1.080 330.213 -1.080

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of $-204.26 mean?
Immunic (IMUX) has a E10 of $-204.26 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Immunic and its competitors.
Is Immunic's E10 too high?
Immunic's current E10 is $-204.26. Overall, Immunic has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Immunic's E10 compare to KPTI and INDP?
Immunic's E10 of $-204.26 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Biotechnology company?
A good E10 depends on the Biotechnology industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Immunic and its competitors. Immunic's current E10 is $-204.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Immunic stock overvalued right now?
Immunic (IMUX) has a current E10 of $-204.26. The current E10 is $-204.26. Immunic's overall GF Score™ is 32/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Immunic (IMUX), the current E10 is $-204.26 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Immunic Business Description

Other Exchanges 10V:Germany
Address 1200 Avenue of the Americas, Suite 200, New York, NY, USA, 10036
Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function. It operates in one segment which is Life science segment.
32GF Score

Get the complete analysis for IMUX

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$15.07
Price